TY  - GEN 
AU  - Oyagüez, I.
AU  - Suárez, C.
AU  - López-Sendón, J. L.
AU  - González Juanatey, José Ramón
AU  - de Andrés-Nogales, F.
AU  - Suárez, J.
AU  - Polanco, C.
AU  - Soto, J.
PY  - 2020
SN  - 2509-4262
UR  - http://hdl.handle.net/20.500.11940/16543
AB  - OBJECTIVE: Our objective was to assess the cost effectiveness of apixaban versus edoxaban in the prevention of stroke and systemic embolism (SE) in patients with atrial fibrillation (AF) in Spain. METHODS: We customized a Markov model with ten health...
TI  - Cost-Effectiveness Analysis of Apixaban Versus Edoxaban in Patients with Atrial Fibrillation for Stroke Prevention
DO  - 10.1007/s41669-019-00186-7
KW  - CHUS
VL  - 4
ER  -